Ioannis Charalampopoulos | Neuroscience | Best Researcher Award

Prof. Ioannis Charalampopoulos
| Neuroscience | Best Researcher Award šŸ†

Professor of Pharmacology at Medical School, University of Crete,GreecešŸŽ“

Dr. Ioannis Charalampopoulos is a distinguished Professor of Pharmacology at the University of Crete’s Medical School and a Group Leader at the Institute of Molecular Biology and Biotechnology (IMBB), Foundation of Research and Technology, Hellas (FORTH). With a focus on neuropharmacology and molecular biology, his research has contributed significantly to the study of neurodegenerative diseases, brain development, and regeneration. He has an extensive academic and research career spanning over two decades, with notable achievements in the development of novel therapeutic strategies for Alzheimer’s and spinal cord injury.

 

Professional ProfileĀ 

Education šŸŽ“:

  • 2021-present: Director of the Graduate Program in Neurosciences, Medical School, University of Crete
  • 2010-2023: Lecturer, Assistant and Associate Professor of Pharmacology, Medical School, University of Crete
  • 2007-2010: Researcher, Medical School, University of Crete
  • 2005-2007: Post-doctoral Fellow, Molecular Neurobiology Lab, Karolinska Institutet, Sweden
  • 2001-2005: PhD in Pharmacology, Medical School, University of Crete
  • 1998-2000: Master of Science in Neurosciences, Medical School, University of Crete
  • 1990-1996: BSc, Department of Biology, University of Patras

Work Experience šŸ’¼:

  • 2023-present: Professor of Pharmacology, Medical School, University of Crete
  • 2018-present: Researcher/Group Leader, Institute of Molecular Biology and Biotechnology (IMBB), FORTH
  • 2021-present: Director, Graduate Program in Neurosciences, Medical School, University of Crete
  • 2010-2023: Lecturer, Assistant and Associate Professor of Pharmacology, University of Crete
  • 2007-2010: Researcher, Medical School, University of Crete
  • 2005-2007: Post-doctoral Fellow, Molecular Neurobiology Lab, Karolinska Institutet, Sweden

Skills šŸ”

Dr. Charalampopoulos is highly skilled in neuropharmacology, molecular biology techniques, and neurodegenerative disease research. His expertise includes:

  • Neurotrophin receptor structure-function analysis
  • Development of therapeutic ligands for brain regeneration
  • Neurogenesis and neuroprotection strategies
  • Animal models of Alzheimer’s disease and spinal cord injury
  • Human iPSC-derived neural platforms for disease modeling
  • Collaborative research in neuroscience and pharmacology

Awards and Honors šŸ†

Dr. Charalampopoulos has received multiple recognitions throughout his career, including prestigious grants for his innovative work in neuroscience and neurodegenerative disease treatment:

  • HORIZON-EIC-2022 European Commission Grant: Coordinating a project on soft-robot-assisted therapeutic delivery for neurological disorders (budget: 2.9 million euros).
  • National Flagship Project: Funding for the elucidation of the genetic basis of Alzheimer’s and Parkinson’s diseases (budget: 610,000 euros).
  • Numerous research accolades, with over 80 publications in peer-reviewed journals (h-index: 35, citations >3000).

šŸ¤ Memberships:

Dr. Charalampopoulos is a member of several prestigious scientific organizations, including:

  • International Society for Neuroscience
  • European Society of Neurochemistry
  • Society for Neuroscience (SfN)
  • Greek Society for Pharmacology

Teaching Experience šŸ‘©ā€šŸ«:

Dr. Charalampopoulos has been actively involved in educating future generations of neuroscientists, particularly through his role as the Director of the Graduate Program in Neurosciences at the University of Crete. His teaching experience includes:

  • Undergraduate and postgraduate courses in pharmacology, neuropharmacology, and molecular biology.
  • Mentoring and supervising PhD students and postdoctoral researchers in pharmacology and neuroscience.
  • Developing innovative teaching methods, including the use of human stem cell models in neuroscience research.

Research Focus šŸ”¬:

Dr. Charalampopoulos’ research interests revolve around the molecular mechanisms by which growth factors and their receptors regulate the regenerative capacity of the nervous system. Key areas include:

  • Neurotrophins: Their role in brain development, neurogenesis, neuronal survival, and repair during aging.
  • Neurodegenerative Diseases: Investigating novel therapeutic strategies for Alzheimer’s disease, Parkinson’s disease, and spinal cord injury.
  • Ligand Development: Creating novel ligands targeting neurotrophin receptors to enhance regenerative and neuroprotective effects.
  • Stem Cell Models: Using human induced pluripotent stem cell-derived platforms to test therapeutics for neurodegenerative diseases.
    His ultimate goal is to decipher the signaling mechanisms underlying neurodegeneration and regeneration, leading to the development of novel drugs for brain repair.
ConclusionĀ 

Dr. Ioannis Charalampopoulos is undoubtedly a top contender for the Best Researcher Award. His exceptional contributions to neuroscience, his innovative approaches in neuropharmacology, and his ability to secure substantial research funding demonstrate that he is not only an accomplished researcher but also a transformative figure in the field of neurodegenerative diseases. His strengths lie in the originality of his work, leadership in research initiatives, and mentorship in education. With slight improvements in public outreach, collaborative networks, and clinical translation, he can further elevate his already remarkable career. Therefore, Dr. Charalampopoulos is a highly deserving nominee for the Best Researcher Award, given his outstanding scientific contributions, leadership, and lasting impact on the field of neuroscience.

šŸ“š Publilcation

  • “Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer’s disease”
    • Year: 2024
    • Journal: Frontiers in Cellular Neuroscience
    • Type: Review
    • DOI: 10.3389/fncel.2024.1422130
  • “Editorial: Steroid receptors in neuron and glia”
    • Year: 2024
    • Journal: Frontiers in Endocrinology
    • Type: Editorial
    • DOI: 10.3389/fendo.2024.1472908
  • “Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer’s disease”
    • Year: 2024
    • Journal: Stem Cell Research & Therapy
    • Type: Journal Article
    • DOI: 10.1186/s13287-024-03818-w
  • “Cover Image, Volume 72, Issue 4”
    • Year: 2024
    • Journal: Glia
    • Type: Journal Article
    • DOI: 10.1002/glia.24399
  • “Dynamics of myelin deficits in the 5xFAD mouse model for Alzheimer’s disease and the protective role of BDNF”
    • Year: 2024
    • Journal: Glia
    • Type: Journal Article
    • DOI: 10.1002/glia.24505
  • “Multimodal beneficial effects of BNN27, a Nerve Growth Factor synthetic mimetic, in the 5xFAD mouse model of Alzheimer’s Disease”
    • Year: 2024
    • Type: Preprint
    • DOI: 10.21203/rs.3.rs-3886007/v1
  • “Development of Pleiotropic TrkB and 5-HT<sub>4</sub> Receptor Ligands as Neuroprotective Agents”
    • Year: 2024
    • Journal: Molecules
    • Type: Journal Article
    • DOI: 10.3390/molecules29020515
  • “Butanolides and Butenolides from a Marine-Derived Streptomyces sp. Exert Neuroprotective Activity through Activation of the TrkB Neurotrophin Receptor”
    • Year: 2023
    • Journal: Marine Drugs
    • Type: Journal Article
    • DOI: 10.3390/md21090465
  • “Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor, Regulating Neuronal Survival in a Cell Context-Dependent Manner”
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
    • Type: Journal Article
    • DOI: 10.3390/ijms241411683
  • “Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor Promoting Cell Death in Mouse and Human Neuronal Cells”
    • Year: 2023
    • Type: Preprint
    • DOI: 10.20944/preprints202306.1633.v1

Dr. Menghuan Wang | Cognitive Rehabilitation | Young Scientist Award

Dr. Menghuan Wang | Cognitive Rehabilitation | Young Scientist Award šŸ†

Ph.D at Nanjing Normal University ,ChinašŸŽ“

šŸ‘Øā€šŸ”¬ Menghuan Wang is a dedicated PhD candidate in the field of neurorehabilitation at Nanjing Normal University, with previous academic affiliations at Nanjing Medical University. His research is centered on enhancing cognitive and motor function through non-invasive brain stimulation and innovative therapies. Wang has focused on impactful treatments for aphasia and stroke patients, as well as those undergoing maintenance hemodialysis.

 

Professional ProfileĀ 

Education šŸŽ“:

šŸŽ“ PhD Candidate, Nanjing Normal University – Specializing in neurorehabilitation, Wang’s academic training includes expertise in functional near-infrared spectroscopy (fNIRS) and advanced brain stimulation methods such as transcranial magnetic stimulation (TMS) and transcutaneous auricular vagus nerve stimulation (taVNS).

Work Experience šŸ’¼:

šŸ’¼ Research and Innovation – Wang has led and collaborated on significant research projects aimed at improving patient-centered neurorehabilitation, with 15 research publications in both English and Chinese journals. His work has influenced approaches to cognitive function restoration and non-invasive therapeutic techniques.

Skills šŸ”

  • Neurorehabilitation Techniques: Proficient in fNIRS, TMS, tES, and taVNS.
  • Patient-Centered Research: Developing therapies for patients with cognitive impairment and motor challenges, focusing on post-stroke recovery and cognitive decline prevention in dialysis patients.
  • Cognitive and Motor Function Restoration: Employing non-invasive brain stimulation to achieve measurable rehabilitation outcomes.

Awards and Honors šŸ†

šŸ† Award Nominee – Menghuan Wang is nominated for the Young Scientist Award and Best Researcher Award, recognizing his substantial contributions to cognitive science and neurorehabilitation. His work has garnered citations and recognition, particularly within Chinese and international scientific communities.

šŸ¤ Memberships:

šŸ¤ Professional Affiliations

  • Member, Branch of Cognitive Neurobiology, Chinese Neuroscience Society
  • Member, Chinese Association of Rehabilitation Medicine
    These memberships underscore Wang’s active engagement with prominent cognitive and rehabilitation networks.

Teaching Experience šŸ‘©ā€šŸ«:

Mentorship and Knowledge Sharing – As an advanced researcher, Wang frequently collaborates with peers, guiding team-based research projects and contributing to knowledge-building within his field.

Research Focus šŸ”¬:

Wang’s research focuses on cognitive neuroscience, neurolinguistics, and neuromodulation, with a particular emphasis on neurorehabilitation. His pioneering studies on taVNS for hemodialysis patients have shown promise in preventing cognitive impairment, offering new paths in non-invasive brain treatments.

ConclusionĀ 

Menghuan Wang’s research contributions make him a compelling candidate for the Young Scientist Award. His innovative use of non-invasive neuromodulation techniques in neurorehabilitation reflects both academic rigor and a commitment to patient-centered care. With a growing publication record and substantial clinical relevance, Wang shows strong potential to advance the field of cognitive neuroscience. Further expanding his collaborative and leadership roles could strengthen his profile even further, but his current accomplishments already showcase a high level of scientific achievement and innovation that aligns well with the spirit of the Young Scientist Award.

šŸ“š PublilcationĀ 

  • Transcutaneous Auricular Vagus Nerve Stimulation Combined with Task-Oriented Training to Improve Upper Extremity Function in Post-Stroke Hemiplegia
    • Year: 2024
    • Journal: Chinese Journal of Rehabilitation Medicine (Vol. 39, Issue 6, pp. 782–790)
    • Authors: Wang, M., Kong, Y., Xie, M.
  • ZNF217-Activated Notch Signaling Mediates Sulforaphane-Suppressed Stem Cell Properties in Colorectal Cancer
    • Year: 2024
    • Journal: Journal of Nutritional Biochemistry (Vol. 125, Article 109551)
    • Authors: Wang, M., Tang, L., Chen, S., Li, Y., Chen, Y.
  • Transcutaneous Auricular Vagus Nerve Stimulation Improves Cognitive Decline by Alleviating Intradialytic Cerebral Hypoxia in Hemodialysis Patients: A fNIRS Pilot Study
    • Year: 2024
    • Journal: Heliyon (Article e39841)
    • Authors: Wang, M.-H., Jin, Y.-J., He, M.-F., Li, W.-W., Jiang, Z.-L.
  • Transcutaneous Auricular Vagus Nerve Stimulation with Task-Oriented Training Improves Upper Extremity Function in Patients with Subacute Stroke: A Randomized Clinical Trial
    • Year: 2024
    • Journal: Frontiers in Neuroscience (Vol. 18, Article 1346634)
    • Authors: Wang, M.-H., Wang, Y.-X., Xie, M., Lin, F., Jiang, Z.-L.
  • Diallyl Trisulfide Inhibits Gastric Cancer Stem Cell Properties Through Ī”Np63/Sonic Hedgehog Pathway
    • Year: 2023
    • Journal: Molecular Carcinogenesis (Vol. 62, Issue 11, pp. 1673–1685)
    • Authors: Ge, M., Zhu, J., Yi, K., Jiang, Z., Han, H.
  • Transcranial Direct Current Stimulation Improves the Attention and Executive Function in Patients with Maintenance Hemodialysis
    • Year: 2023
    • Journal: Chinese Journal of Rehabilitation Medicine (Vol. 38, Issue 9, pp. 1221–1226)
    • Authors: Chen, L., Wang, M., Li, W.
  • TEADs Serve as Potential Prognostic Biomarkers and Targets for Human Gastric Cancer
    • Year: 2022
    • Journal: BMC Gastroenterology (Vol. 22, Issue 1, Article 308)
    • Authors: Wang, M.-H., Li, B.-Z., Chen, Y., Wang, J.
  • Ī”Np63α Mediates Sulforaphane-Suppressed Colorectal Cancer Stem Cell Properties Through Transcriptional Regulation of Nanog/Oct4/Sox2
    • Year: 2022
    • Journal: Journal of Nutritional Biochemistry (Vol. 107, Article 109067)
    • Authors: Chen, Y., Wang, M.-H., Wu, J.-Y., Han, H.-Y., Zhong, C.-Y.
  • TAp63α Targeting of Lgr5 Mediates Colorectal Cancer Stem Cell Properties and Sulforaphane Inhibition
    • Year: 2020
    • Journal: Oncogenesis (Vol. 9, Issue 10, Article 89)
    • Authors: Chen, Y., Wang, M.-H., Zhu, J.-Y., Han, H.-Y., Zhong, C.-Y.

Prof. Dr. binli | Neuroscience | Best Researcher Award

Prof. Dr. binli | Neuroscience | Best Researcher Award šŸ†

Lecturer (University Professor) at yangzhou university,ChinašŸŽ“

The nominee, a PhD holder in Architecture since 2016, has demonstrated excellence in research, education, and practical applications in architecture and sustainability. His dual focus on comfort and accessibility, alongside nature-based solutions for climate resilience, addresses critical contemporary issues. His notable contributions, backed by research grants and real-world projects, underscore his commitment to advancing sustainable architecture.

 

Professional ProfileĀ 

šŸŽ“ Education

Bin Li earned his Ph.D. in Neuroscience from Nanjing Agricultural University, where his master’s thesis was recognized as an excellent thesis. His educational background laid a strong foundation for his expertise in neuroimmunology and endothelial cell research. šŸŽ“šŸ†

šŸ¢ Work Experience

As a university-appointed professor, Bin has made significant contributions to the field of Neuroscience. His work focuses on the mechanisms of mRNA methylation in endothelial cells and their role in recovery after ischemic stroke, enhancing our understanding of neurovascular repair processes. šŸ§ šŸ„

🧬 Skills

  • Bin possesses advanced research skills in molecular biology and neuroimmunology, with a strong capability in conducting complex experiments and data analysis. His ability to communicate complex scientific concepts effectively enhances his teaching and mentorship roles. šŸ§ŖšŸ“Š

Awards and Honors šŸ†

He has received numerous accolades, including the “Lv Yang Jin Feng” Outstanding Doctor award and recognition for an outstanding paper at the 19th National Academic Exchange Meeting on Neuropsychopharmacology in 2021. šŸ„‡šŸŽ–ļø

MembershipsšŸ“œĀ 

Bin is an active member of professional organizations, including the Neuroimmunology Branch of the Jiangsu Society of Immunology and the Basic Veterinary Branch of the Jiangsu Animal Husbandry and Veterinary Association, which facilitate collaboration and knowledge exchange in his field. šŸ¤šŸŒ

šŸ“š Teaching Experience

In his role as a lecturer, Bin is dedicated to educating the next generation of scientists, fostering a stimulating learning environment, and guiding students through advanced concepts in Neuroscience and immunology. šŸ“–šŸ‘Øā€šŸ«

šŸ”¬ Research Focus

His current research investigates glial cell-to-neuron and endothelial cell inter-communication during post-ischemic injury, aiming to uncover novel therapeutic strategies for brain recovery. With a total of 12 published papers and significant citations, his research is influential in the field. šŸ”šŸ§¬

ConclusionĀ 

In conclusion, Dr. Bin Li exemplifies the qualities of a leading researcher deserving of the Best Researcher Award. His innovative research, impressive publication record, and active engagement in the scientific community highlight his significant contributions to neuroscience. Addressing the areas for improvement could further amplify his impact, making him a valuable asset to both academia and society. Dr. Li’s commitment to advancing knowledge in neurovascular repair positions him as an outstanding candidate for this prestigious recognition.

šŸ“š PublilcationĀ 

  • EHR coding with hybrid attention and features propagation on disease knowledge graph
    • Year: 2024
    • Journal: Artificial Intelligence in Medicine
  • DAJLENet: A neural network based on dual attention and joint learning for explainable heart failure adverse event prediction
    • Year: 2024
    • Journal: Computers and Electrical Engineering
  • Application programming interface recommendation for smart contract using deep learning from augmented code representation
    • Year: 2024
    • Journal: Journal of Software: Evolution and Process
  • Extraction of Corn Plant Phenotypic Parameters with Keypoint Detection and Stereo Images
    • Year: 2024
    • Journal: Agronomy
  • Ponzi Scheme Detection in Smart Contract via Transaction Semantic Representation Learning
    • Year: 2024
    • Journal: IEEE Transactions on Reliability
  • Normalization of kinship relations to enrich family network analysis: case study on China biographical database
    • Year: 2024
    • Journal: Digital Scholarship in the Humanities
  • Fine-grained smart contract vulnerability detection by heterogeneous code feature learning and automated dataset construction
    • Year: 2024
    • Journal: Journal of Systems and Software
  • Neurodynamics for Equality-Constrained Time-Variant Nonlinear Optimization Using Discretization
    • Year: 2024
    • Journal: IEEE Transactions on Industrial Informatics
  • Automatic software vulnerability classification by extracting vulnerability triggers
    • Year: 2024
    • Journal: Journal of Software: Evolution and Process